Voltarelli JC, Couri CE.
Department of Clinical Medicine, Ribeirão Preto School of Medicine, University of São Paulo, Brazil. This e-mail address is being protected from spambots. You need JavaScript enabled to view it
ABSTRACT: BACKGROUND: The use of stem cells to treat type 1 diabetes mellitus has been proposed for many years, both to downregulate the immune system and to provide beta cell regeneration. CONCLUSION: High dose immunosuppression followed by autologous hematopoietic stem cell transplantation is able to induce complete remission (insulin independence) in most patients with early onset type 1 diabetes mellitus.
PMID: 19825196
| < Prev | Next > |
|---|
